Alibasa, Ramiya .
HRN: 22-35-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/22/2022
12/28/2022
IVT
175mg
Q6
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes